Inside Health Folgen

Penis fillers were an unexpected talking point at the recent Winter Olympics after claims that male ski jumpers were having them to improve performance.So this week we’re digging into the UK’s penis filler industry.James visits a private clinic in Manchester to hear about about the procedure, which involves hyaluronic acid being injected to temporarily increase penis girth. He meets Jason, who had his first penis filler five months’ ago, and he explains why he wanted it and how he weighed up the risks versus the benefits.James also chats to an NHS surgeon who says increasing numbers of men are seeking out the procedure - and he is dealing with the consequences when it goes wrong.Also this week, why is aspirin in short supply? Presenter: James Gallagher Producer: Gerry Holt Editor: Ilan Goodman Production coordinator: Stuart Laws Sound engineer: Emma Harth The show was made by the BBC’s Audio Science Unit in collaboration with The Open University.

ME – also known as Chronic Fatigue Syndrome – has long been one of medicine’s most perplexing conditions. With no definitive diagnostic test and a legacy of scepticism in parts of the medical community, patients have often struggled to be believed. But a surge of new research may finally be shifting the landscape. The emergence of Long COVID – a condition with striking similarities to ME – has accelerated scientific interest and opened new lines of inquiry into the underlying biology of both illnesses.In this episode, James Gallagher speaks to Dr Chris Ponting about the latest DecodeME results, which point to a strong genetic component to ME. And Professor Rosemary Boyton outlines the ambition behind the new Rosetta Stone study, designed to build a detailed evidence base of shared biomarkers across ME and Long COVID. James also hears from Catherine and Jo, who have lived with ME for many years. They describe their diagnostic journeys and how they manage their symptoms in their daily lives. Presenter: James Gallagher Producer: Alice Lipscombe-Southwell Researcher: Tom Hunt Editors: Erika Wright and Ilan Goodman

Over 1.5million adults in the UK tried weight loss drugs in 2024-25. Many swear by them, but they have been associated with side effects including nausea and, in some cases, extremely painful gallstones. But what does the evidence actually tell us, and what is the wider impact on the way we view our bodies in society?James Gallagher is joined by Professor of Cardiometabolic Medicine at the University of Glasgow Naveed Sattar, Dr Beverley O’Hara, Lecturer in Public Health Nutrition at Leeds Beckett University, and Dr Margaret McCartney, resident Inside Health GP. They discuss what the evidence tells us about the potential known side effects of these weight loss drugs, and the potential impact their use has on our view of obesity as a society. We also hear from Sarah Le Brocq, who has struggled with obesity all her adult life and has been on these drugs for the past 2-3 years about her experiences. Margaret McCartney has no conflicts of interest to declare.Beverley O’Hara has no conflicts of interest to declare. She has 2 roles with the Association for the Study of Obesity (voluntary academic positions).Naveed Sattar has consulted for and/or received speaker honoraria from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gan & Lee, GlaxoSmithKline, Hanmi Pharmaceuticals, Kailera, Mass Medicines, Menarini-Ricerche, Metsera, Novo Nordisk, Pfizer, Regeneron, Roche, UCB Pharma, and Verdiva Bio; and received grant support paid to his University from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche.Presenter: James Gallagher Producer: Hannah Fisher Researcher: Tom Hunt Production coordinator: Stuart Laws Content Editor: Ilan Goodman